Integra LifeSciences suspends new patient enrollment in the clinical trial for DuraGen Plus Adhesion Barrier Matrix in spinal surgery

By

    
 Integra announced that it will suspend the enrollment of new patients in the clinical trial for DuraGen Plus® Adhesion Barrier Matrix for evaluating the safety and effectiveness as an adhesion barrier in spinal surgery.
SEC Filing…  http://ow.ly/DcPs
...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.